Givlaari (givosiran) is the most exciting development in the acute hepatic porphyria (AHP) community since Panhematin (hemin for injection)…
Claire Richmond
Claire Richmond was diagnosed with acute intermittent porphyria in 2017 after living with unexplained pain for 19 years. She was 32 years old and quickly learned there’s no guidebook for incorporating a strange rare disease into her life. When she could no longer work full time, she struggled to find her purpose. That’s when she began to write. Claire hopes speaking her truth will build connections and generate hope. She lives in Des Moines, Iowa, with her family and rescue poodle.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Claire Richmond
The holidays are a tricky time for people living with chronic illnesses like acute hepatic porphyria (AHP). My body doesn’t…
My neighborhood pharmacy was randomly closed last Friday. Given the amount of medications I use to manage symptoms of acute…
My rich and complex history with hormones started at age 15, when I turned to various estrogen and progestin combos…
The presentation began and I found my seat. Looking around the meeting room, I knew that every single person was…
I have a confession to make. I’ve read the “Twilight” saga. Yes, even the “Eclipse” novella about the…
The U.S. healthcare system is good at helping people in crisis get over the hump. But what if your disease…
I had a short-lived, yet severe, acute hepatic porphyria (AHP) attack in mid-September. Like a descending tornado, it came…
I run late. I sleep in. I am a slow processor. I only have so much control over my pain…
Well, I finally did it. I started Givlaari (givosiran). Since my diagnosis in 2017, the development of this new…